Skip to main content
. 2019 Mar 15;8(3):252. doi: 10.3390/cells8030252
HCV Hepatitis C
RBV Ribavirin
PrOD Paritaprevir/ritonavir/ombitasvir/dasabuvir
CAP Controlled attenuation parameter
SVR Sustained virologic response
LDL-C Low-density lipoprotein cholesterol
HOMA-IR Homeostatic model assessment—insulin resistance
HCC Hepatocellular carcinoma
VLDL Very-low-density lipoprotein
TG Triglycerides
HDL-C High-density lipoprotein cholesterol
DAA Direct acting antivirals
RNA Ribonucleic acid
REB Research Ethics Board
kPa Kilopascal
BMI Body mass index
IFN Interferon
HbA1c Glycated hemoglobin
LVP Lipo-viral particles